# A Study of Nipocalimab With Co-administration of Etanercept or Hydroxychloroquine in Healthy Participants

> **NCT04973566** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 48 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Nipocalimab
- **DRUG:** Etanercept
- **DRUG:** Hydroxychloroquine

## Key facts

- **NCT ID:** NCT04973566
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-31
- **Primary completion:** 2022-05-27
- **Final completion:** 2022-05-27
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2025-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04973566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04973566, "A Study of Nipocalimab With Co-administration of Etanercept or Hydroxychloroquine in Healthy Participants". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04973566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*